-
1
-
-
70349774235
-
Clinical laboratory reference intervals in pediatrics: the CALIPER initiative
-
Jung B., Adeli K. Clinical laboratory reference intervals in pediatrics: the CALIPER initiative. Clin Biochem 2009, 42:1589-1595.
-
(2009)
Clin Biochem
, vol.42
, pp. 1589-1595
-
-
Jung, B.1
Adeli, K.2
-
2
-
-
77956173020
-
Closing the gaps in paediatric reference intervals: the CALIPER initiative
-
Schnabl K., Chan M.K., Gong Y., Adeli K. Closing the gaps in paediatric reference intervals: the CALIPER initiative. The Clinical Biochemist Reviews/Australian Association of Clinical Biochemists 2008, 29:89-96.
-
(2008)
The Clinical Biochemist Reviews/Australian Association of Clinical Biochemists
, vol.29
, pp. 89-96
-
-
Schnabl, K.1
Chan, M.K.2
Gong, Y.3
Adeli, K.4
-
3
-
-
12444249946
-
Reference intervals: an update
-
Horn P.S., Pesce A.J. Reference intervals: an update. Clin Chim Acta 2003, 334:5-23.
-
(2003)
Clin Chim Acta
, vol.334
, pp. 5-23
-
-
Horn, P.S.1
Pesce, A.J.2
-
4
-
-
84860688864
-
Establishing pediatric reference intervals: a challenging task
-
Ceriotti F. Establishing pediatric reference intervals: a challenging task. Clin Chem 2012, 58:808-810.
-
(2012)
Clin Chem
, vol.58
, pp. 808-810
-
-
Ceriotti, F.1
-
5
-
-
84871625833
-
-
Lab Tests Online. Bone Markers. Available online at Accessed August
-
Lab Tests Online. Bone Markers. Available online at Accessed August, 2011. http://labtestonline/understanding/analytes/bone-markers.
-
(2011)
-
-
-
6
-
-
33745203732
-
Pediatric reference intervals for bone markers
-
Yang L., Grey V. Pediatric reference intervals for bone markers. Clin Biochem 2006, 39:561-568.
-
(2006)
Clin Biochem
, vol.39
, pp. 561-568
-
-
Yang, L.1
Grey, V.2
-
7
-
-
0030795372
-
Serum bone alkaline phosphatase isoenzyme levels in normal children and children with growth hormone (GH) deficiency: a potential marker for bone formation and response to GH therapy
-
Tobiume H., Kanzaki S., Hida S., et al. Serum bone alkaline phosphatase isoenzyme levels in normal children and children with growth hormone (GH) deficiency: a potential marker for bone formation and response to GH therapy. J Clin Endocrinol Metab 1997, 82:2056-2061.
-
(1997)
J Clin Endocrinol Metab
, vol.82
, pp. 2056-2061
-
-
Tobiume, H.1
Kanzaki, S.2
Hida, S.3
-
9
-
-
0035173497
-
Pediatric reference ranges for osteocalcin measured by the Immulite analyzer
-
Seydewitz H.H., Henschen M., Kuhnel W., Brandis M. Pediatric reference ranges for osteocalcin measured by the Immulite analyzer. Clin Chem Lab Med 2001, 39:980-982.
-
(2001)
Clin Chem Lab Med
, vol.39
, pp. 980-982
-
-
Seydewitz, H.H.1
Henschen, M.2
Kuhnel, W.3
Brandis, M.4
-
10
-
-
33845968165
-
Serum osteocalcin and parathyroid hormone in healthy children assessed with two new automated assays
-
Vietri M.T., Sessa M., Pilla P., et al. Serum osteocalcin and parathyroid hormone in healthy children assessed with two new automated assays. J Pediatr Endocrinol Metab 2006, 19:1413-1419.
-
(2006)
J Pediatr Endocrinol Metab
, vol.19
, pp. 1413-1419
-
-
Vietri, M.T.1
Sessa, M.2
Pilla, P.3
-
11
-
-
0031059363
-
Serum osteocalcin in 1634 healthy children
-
Cioffi M., Molinari A.M., Gazzerro P., et al. Serum osteocalcin in 1634 healthy children. Clin Chem 1997, 43:543-545.
-
(1997)
Clin Chem
, vol.43
, pp. 543-545
-
-
Cioffi, M.1
Molinari, A.M.2
Gazzerro, P.3
-
13
-
-
0026768012
-
Serum levels of carboxyterminal propeptide of type I procollagen in healthy children from 1st year of life to adulthood and in metabolic bone diseases
-
Saggese G., Bertelloni S., Baroncelli G.I., Di Nero G. Serum levels of carboxyterminal propeptide of type I procollagen in healthy children from 1st year of life to adulthood and in metabolic bone diseases. Eur J Pediatr 1992, 151:764-768.
-
(1992)
Eur J Pediatr
, vol.151
, pp. 764-768
-
-
Saggese, G.1
Bertelloni, S.2
Baroncelli, G.I.3
Di Nero, G.4
-
14
-
-
0028860874
-
Serum levels of carboxyterminal propeptide of type I procollagen and pyridinoline crosslinked telopeptide of type I collagen in normal children and children with growth hormone (GH) deficiency during GH therapy
-
Kubo T., Tanaka H., Inoue M., Kanzaki S., Seino Y. Serum levels of carboxyterminal propeptide of type I procollagen and pyridinoline crosslinked telopeptide of type I collagen in normal children and children with growth hormone (GH) deficiency during GH therapy. Bone 1995, 17:397-401.
-
(1995)
Bone
, vol.17
, pp. 397-401
-
-
Kubo, T.1
Tanaka, H.2
Inoue, M.3
Kanzaki, S.4
Seino, Y.5
-
15
-
-
0025837681
-
Serum concentrations of the type I and III procollagen propeptides as biochemical markers of growth velocity in healthy infants and children and in children with growth disorders
-
Trivedi P., Risteli J., Risteli L., Hindmarsh P.C., Brook C.G., Mowat A.P. Serum concentrations of the type I and III procollagen propeptides as biochemical markers of growth velocity in healthy infants and children and in children with growth disorders. Pediatr Res 1991, 30:276-280.
-
(1991)
Pediatr Res
, vol.30
, pp. 276-280
-
-
Trivedi, P.1
Risteli, J.2
Risteli, L.3
Hindmarsh, P.C.4
Brook, C.G.5
Mowat, A.P.6
-
16
-
-
0036201287
-
Serum CrossLaps: pediatric reference intervals from birth to 19years of age
-
Crofton P.M., Evans N., Taylor M.R., Holland C.V. Serum CrossLaps: pediatric reference intervals from birth to 19years of age. Clin Chem 2002, 48:671-673.
-
(2002)
Clin Chem
, vol.48
, pp. 671-673
-
-
Crofton, P.M.1
Evans, N.2
Taylor, M.R.3
Holland, C.V.4
|